Pharmacopsychiatry 2008; 41(4): 163-165
DOI: 10.1055/s-2008-1076723
Letter

© Georg Thieme Verlag KG Stuttgart · New York

Thyrotoxicosis after Iodine Contrast Medium Administration: Rapid Mood Swing to Mania and Subsequent Psychotic Depression in a Patient with Bipolar Disorder during Lithium Therapy

S. Arlt 1 , D. Burkhardt 1 , K. Wiedemann 1
  • 1Department of Psychiatry and Psychotherapy, University of Hamburg Medical Center, Hamburg, Germany
Further Information

Publication History

received 13.08.2007 revised 21.01.2008

accepted 29.01.2008

Publication Date:
23 July 2008 (online)

Interactions between lithium treatment and thyroid function are well known and the risk of hypothyroidism is widely recognized by clinicians. In addition, a higher presence of thyroid antibodies has been described in bipolar disorders independent of lithium exposure. We present a case of severe thyrotoxicosis with a rapid mood swing to mania and subsequent psychotic depression in a 56-year-old woman with bipolar disorder during lithium therapy following the administration of iodine contrast medium. On the basis of this case report and existing literature it seems advisable to closely monitor not only thyroid hormones but also thyroid antibodies in patients with bipolar disorders.

References

  • 1 Bocchetta A, Loviselli A. Lithium treatment and thyroid abnormalities.  Clin Pract Epidemol Ment Health. 2006;  2 23
  • 2 Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth?.  Arch Neurol. 2003;  60 164-171
  • 3 Crowe MJ, Lloyd GG, Bloch S, Rosser RM. Hypothyroidism in patients treated with lithium: a review and two case reports.  Psychol Med. 1973;  3 337-342
  • 4 Dang AH, Hershman JM. Lithium-associated thyroiditis.  Endocr Pract. 2002;  8 232-236
  • 5 Iga J, Taniguchi T, Ohmori T. Mood swing from severe depression to mania following acute alteration of thyroid status.  Gen Hosp Psychiatry. 2005;  27 451-453
  • 6 Kupka RW, Nolen WA, Post RM, MacElroy SL, Altshuler LL, Denicoff KD, Frye MA, Keck  Jr  PE, Leverich GS, Rush AJ, Suppes T, Pollio C, Drexhage HA. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure.  Biol Psychiatry. 2002;  51 305-311
  • 7 Mouaffak F, Gourevitch R, Baup N, Lôo H, Olié JP. Interrelations between lithium therapy, auto-immune thyroiditis and TSH. A case report.  Pharmacopsychiatry. 2006;  39 77-78
  • 8 Pandit L, Shankar SK, Gayathri N, Pandit A. Acute thyrotoxic neuropathy – Basedow's paraplegia revisited.  J Neurol Sci. 1998;  155 211-214
  • 9 Schöpf J, Lemarchand T. Lithium addition in endogenous depressions resistant to tricyclic antidepressants or related drugs: relation to the status of the pituitary-thyroid axis.  Pharmacopsychiatry. 1994;  27 198-201
  • 10 Schou M, Amdisen A, Eskjaer Jensen S, Olsen T. Occurrence of goitre during lithium treatment.  Br Med J. 1968;  3 ((5620)) 710-713
  • 11 Szuba MP, Amsterdam JD, Fernando  3rd  AT, Gary KA, Whybrow PC, Winokur A. Rapid antidepressant response after nocturnal TRH administration in patients with bipolar type I and bipolar type II major depression.  J Clin Psychopharmacol. 2005;  25 325-330
  • 12 Tavintharan S, Rajasoorya C. A case report of acute confusional state in thyrotoxicosis.  Ann Acad Med Singapore. 1998;  27 586-588
  • 13 Temple R, Berman M, Robbins J, Wolff J. The use of lithium in the treatment of thyrotoxicosis.  J Clin Invest. 1972;  51 2746-2756

Correspondence

Dr. med. S. Arlt

Department of Psychiatry and Psychotherapy

University of Hamburg Medical Center

Martinistr. 52, S 15

20246 Hamburg

Germany

Phone: +49/40/42803 32 23

Fax: +49/40/42803 34 61

Email: arlt@uke.uni-hamburg.de

    >